COPENHAGEN \u2014 Four patients in Denmark, who experienced vision loss after using Novo Nordisk\u2019s popular weight-loss and diabetes drugs Wegovy and Ozempic, have been granted compensation, the Danish Patient Compensation association said on Friday.<\/p>\n
The two drugs, which contain the active ingredient semaglutide, have been linked in very rare cases to a serious eye condition known as non-arteritic anterior ischemic optic neuropathy (NAION), the European Medicines Agency\u2019s safety committee noted in June. The condition can cause permanent vision loss.<\/p>\n
Following the EMA\u2019s findings, Novo Nordisk updated the labels for Wegovy and Ozempic to state that semaglutide may cause NAION in up to 1 in 10,000 patients.<\/p>\n
The Danish Patient Compensation association, an independent body that evaluates patient claims on behalf of the state, said on Friday it had ruled in five of the 43 claims it received regarding vision loss allegedly linked to the medications. <\/p>\n
Four patients were awarded a combined 800,000 Danish crowns (US$123,253), while one claim was dismissed, it said. The state funds compensation payments awarded by the association.<\/p>\n
The association described the rulings as \u201cvery complex,\u201d requiring input from an optic nerve specialist. <\/p>\n
A Novo Nordisk spokesperson said: \u201cPatient safety is our top priority,\u201d adding that the company \u201cbelieves that the benefit-risk profile of semaglutide remains favorable.\u201d<\/p>\n
(Reporting by Jacob Gronholt-Pedersen. Editing by Mark Potter)<\/p>\n","protected":false},"excerpt":{"rendered":"COPENHAGEN \u2014 Four patients in Denmark, who experienced vision loss after using Novo Nordisk\u2019s popular weight-loss and diabetes…\n","protected":false},"author":2,"featured_media":146560,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33],"tags":[2643,134,524,111,139,69],"class_list":{"0":"post-146559","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-apple-news","9":"tag-health","10":"tag-medication","11":"tag-new-zealand","12":"tag-newzealand","13":"tag-nz"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/146559","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/comments?post=146559"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/146559\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media\/146560"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media?parent=146559"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/categories?post=146559"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/tags?post=146559"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}